A tale of two homocysteines--and two hemodialysis units.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0026-0495(00)91351-9PMID 10690947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients.

  1999cited by this paper
• Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

  1998cited by this paper
• Homocysteine and atherothrombosis.

  1998cited by this paper
• Oral or parenteral therapy for B12 deficiency.

  1998cited by this paper
• Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia.

  1998cited by this paper
• Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

  1998cited by this paper
• Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.

  1998cited by this paper
• The Role of Homocysteine in End‐Stage Renal Disease

  1998cited by this paper
• Homocysteine, folate, vitamin B6, and cardiovascular disease.

  1998cited by this paper
• Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

  1998cited by this paper
• The relationship between plasma homocysteine and amino acid concentrations in patients with end-stage renal disease.

  1998cited by this paper
• Vitamin B-12 deficiency in the elderly: current dilemmas.

  1997cited by this paper
• Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.

  1997cited by this paper
• Determination of Total Homocysteine in Human Plasma by Isocratic High-Performance Liquid Chromatography

  1997cited by this paper
• Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor activity in rats

  1997cited by this paper
• Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over

  1997cited by this paper
• Redox status of plasma homocysteine and related aminothiols in smoking and nonsmoking young adults.

  1997cited by this paper
• Renal homocysteine metabolism.

  1997cited by this paper
• Bioavailability of vitamin B12.

  1997cited by this paper
• Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

  1996cited by this paper
• Homocysteine and vascular disease

  1996cited by this paper
• Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

  1996cited by this paper
• Homocysteinemia and vascular disease in end-stage renal disease.

  1996cited by this paper
• Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

  1996cited by this paper
• Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.

  1996cited by this paper
• The oxidant stress of hyperhomocyst(e)inemia.

  1996cited by this paper
• High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.

  1996cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid

  1995cited by this paper
• Can lowering homocysteine levels reduce cardiovascular risk?

  1995cited by this paper
• Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure.

  1995cited by this paper
• Measurement of homocyst(e)ine in the prediction of arteriosclerosis.

  1995cited by this paper
• Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations.

  1995cited by this paper
• Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects

  1994cited by this paper
• Water soluble vitamins in chronic hemodialysis patients and need for supplementation.

  1993cited by this paper
• Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment.

  1993cited by this paper
• Serum methylmalonic acid in uraemia.

  1992cited by this paper
• Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.

  1992cited by this paper
• Erythropoietin Resistance due to Vitamin B12 Deficiency

  1992cited by this paper
• Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis.

  1987cited by this paper
• Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation.

  1986cited by this paper
• Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism.

  1981cited by this paper
• Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphide

  1979cited by this paper
• Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis.

  1976cited by this paper
• The Megaloblastic Anaemias

  1969cited by this paper

• Effect of Chronic Kidney Disease on Olfactory Function: A Case–Control Study

  2021cites this paper
• بررسی سطح سرمی ویتامین B12 و فولیکاسید در بیماران مبتلا به لیکنپلان و واکنشهای لیکنوئیدی (تماسی- دارویی)

  2014cites this paper
• Hydroxocobalamin supplementation and erythropoisis stimulating agent hyporesponsiveness in haemodialysis patients

  2014cites this paper
• Homocysteine and Hematological Indices in Hemodialysis Patients at Al-Shifa Hospital, Gaza Strip

  2013cites this paper
• Pharmacokinetics and Therapeutic Uses of Mesna

  2010cites this paper
• Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

  2008cites this paper
• Testing the homocysteine hypothesis in end-stage renal disease: Problems and a possible solution.

  2006cites this paper
• Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease.

  2005cites this paper
• Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.

  2005cites this paper
• Effect of vitamin B12 on homocysteine plasma concentration in hemodialysis patients.

  2004cites this paper
• The effect of vitamin B12 on total plasma homocysteine concentration in folate-replete hemodialysis patients.

  2003cites this paper
• Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.

  2003cites this paper
• Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.

  2003cites this paper
• Randomized, placebo‐controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients

  2003cites this paper
• Homocysteine

  2003cites this paper
• 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis.

  2002cites this paper
• Reduction of plasma homocysteine by folic acid in children with chronic renal failure

  2002cites this paper
• The Postdialytic Rise in the Plasma Total Homocysteine Concentration Is Delayed

  2002cites this paper
• Editorial: Renal failure, homocysteine and the pharmacology of vitamin B12.

  2002cites this paper
• Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.

  2002cites this paper
• Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.

  2001cites this paper
• Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.

  2001cites this paper
• Redesigning the map of uremic toxins.

  2001cites this paper
• Plasma reduced homocysteine concentrations are increased in end-stage renal disease.

  2001cites this paper
• Hyperhomocysteinemia Is Related to Residual Glomerular Filtration and Folate, but not to Methylenetetrahydrofolate-Reductase and Methionine Synthase Polymorphisms, in Supplemented End-Stage Renal Disease Patients Undergoing Hemodialysis

  2001cites this paper
• Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease

  2001cites this paper